Skip to main content
73°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nurix Therapeutics Inc
(NQ:
NRIX
)
24.80
+1.23 (+5.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Nurix Therapeutics Inc
< Previous
1
2
3
Next >
The Latest Analyst Ratings for Nurix Therapeutics
October 13, 2023
Via
Benzinga
Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?
September 07, 2023
Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called...
Via
Benzinga
What 4 Analyst Ratings Have To Say About Nurix Therapeutics
September 07, 2023
Via
Benzinga
Designer Brands, Calavo Growers, Couchbase And Other Big Stocks Moving Higher On Thursday
September 07, 2023
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data
July 24, 2023
HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX)
Via
Benzinga
Analyst Ratings for Nurix Therapeutics
July 24, 2023
Via
Benzinga
Nurix Therapeutics's Return On Capital Employed Insights
July 14, 2023
Via
Benzinga
Analyst Ratings for Nurix Therapeutics
April 14, 2023
Via
Benzinga
Expert Ratings for Nurix Therapeutics
March 21, 2023
Via
Benzinga
Gilead Exercises First License Option Under Agreement With Nurix Therapeutics
March 20, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 14, 2023
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday
April 14, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
March 09, 2023
Via
Benzinga
Analyst Ratings for Nurix Therapeutics
February 28, 2023
Via
Benzinga
Nurix Therapeutics's Return On Capital Employed Overview
February 14, 2023
Via
Benzinga
Where Nurix Therapeutics Stands With Analysts
July 08, 2022
Within the last quarter, Nurix Therapeutics (NASDAQ:NRIX) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via
Benzinga
The Top 5 Stocks Cathie Wood Bought and Sold This Week
October 21, 2022
Cathie Wood's flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager.
Via
InvestorPlace
CSX, Veris Residential And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
October 21, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company
October 10, 2022
Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Upgrades
Via
Benzinga
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
September 21, 2022
Gainers
Via
Benzinga
Top Russell 2000 Stocks: Trading Opportunities For Next Week - Sunday, Sept. 11
September 11, 2022
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some Russell 2000 stock...
Via
Talk Markets
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
Why Nurix Therapeutics Shares Are Rising Today
July 08, 2022
Nurix Therapeutics Inc (NASDAQ: NRIX) shares are trading higher by 13.25% to $17.52 Friday afternoon after the company announced a registered direct offering for total gross proceeds of approximately...
Via
Benzinga
Nurix Therapeutics's Return On Capital Employed Insights
July 08, 2022
Benzinga Pro data, Nurix Therapeutics (NASDAQ:NRIX) reported Q2 sales of $11.43 million. Earnings fell to a loss of $45.40 million, resulting in a 6.74% decrease from last quarter.
Via
Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
July 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
40 Stocks Moving In Friday's Mid-Day Session
June 03, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Via
Benzinga
69 Biggest Movers From Friday
June 06, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022
May 31, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.